Bank of New York Mellon Corp - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$265,000
-11.7%
250,0000.0%0.00%
Q2 2019$300,000
+9.5%
250,0000.0%0.00%
Q1 2019$274,000
+11.4%
250,0000.0%0.00%
Q4 2018$246,000
-72.4%
250,000
-70.6%
0.00%
Q3 2018$890,000
-7.9%
850,0000.0%0.00%
Q2 2018$966,000
+3.6%
850,0000.0%0.00%
Q1 2018$932,000
-28.4%
850,000
-0.6%
0.00%
Q4 2017$1,301,000
+41.4%
855,000
+0.6%
0.00%
Q3 2017$920,000
+1.9%
850,0000.0%0.00%
Q2 2017$903,000
-0.1%
850,0000.0%0.00%
Q1 2017$904,000
+56.1%
850,000
+70.0%
0.00%
Q4 2016$579,000
+88.6%
500,000
+100.0%
0.00%
Q3 2016$307,000
-81.7%
250,000
-83.9%
0.00%
-100.0%
Q2 2016$1,676,000
+134.4%
1,550,000
+93.8%
0.00%
Q1 2016$715,000
-45.3%
800,000
-38.5%
0.00%
Q4 2015$1,307,000
+10.0%
1,300,0000.0%0.00%
Q3 2015$1,188,000
-20.3%
1,300,0000.0%0.00%
Q2 2015$1,491,000
-0.6%
1,300,0000.0%0.00%
Q1 2015$1,500,0001,300,0000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Wellesley Asset Management 56,030$64,610,0003.40%
MANGROVE PARTNERS IM, LLC 18,779$21,537,0002.90%
Worth Venture Partners, LLC 1,102,000$1,275,0001.41%
DLD Asset Management, LP 10,250,000$11,896,0000.86%
Perceptive Advisors 7,500,000$8,642,0000.29%
OAKTREE CAPITAL MANAGEMENT LP 12,719,000$14,666,0000.23%
CAMDEN ASSET MANAGEMENT L P /CA 3,416,000$3,922,0000.15%
PALISADE CAPITAL MANAGEMENT, LP 1,500,000$1,733,0000.06%
Certified Advisory Corp 42,000$48,0000.03%
CSS LLC/IL 500,000$577,0000.03%
View complete list of ANI PHARMACEUTICALS INC shareholders